Abstract

BackgroundFrailty is prevalent among patients with end-stage renal disease (ESRD) and is associated with an increased risk of cognitive impairment. However, apart from its influence on cognition, it is currently unknown whether frailty affects subtler cerebral function in patients with ESRD.MethodsPatients with ESRD were prospectively enrolled, with clinical features and laboratory data recorded. The severity of frailty among these patients with ESRD was ascertained using the previously validated simple FRAIL scale, and was categorized as none-to-mild and moderate-to-severe frailty. All participants underwent quantitative electroencephalography (EEG), with band powers documented following the generation of the delta to alpha ratio (DAR) and delta/theta to alpha/beta ratio (DTABR). EEG results were then compared between groups of different levels of frailty.ResultsIn this cohort, (mean age: 68.9 ± 10.4 years, 37% male, 3.4 ± 3 years of dialysis), 20, 60, 40, 17, and 6% patients exhibited positivity in the fatigue, resistance, ambulation, illness, and loss-of-body-weight domains, respectively, with 45.7% being none to mildly frail and 54.3% being moderately to severely frail. Those with mild frailty had a significantly higher delta power compared to those with more severe frailty, involving all topographic sites. Patients with ESRD and severe frailty had significantly lower global, left frontal, left temporo-occipital, and right temporo-occipital DAR and DTABR, except in the right frontal area, and tended to have central accentuation of alpha, beta, and theta power, and more homogeneous DTABR and DAR distribution compared to the findings in those with mild frailty.ConclusionsFrailty in patients with ESRD can have subtler neurophysiological influences, presenting as altered EEG findings, which warrant our attention.

Highlights

  • Frailty is prevalent among patients with end-stage renal disease (ESRD) and is associated with an increased risk of cognitive impairment

  • Through the assistance of quantitative EEG, we aimed to examine the differences in cortical activities from patients with ESRD, based on their levels of frailty, and explore the clinical implications

  • Using simple frail scale (SFS) as previously described [14, 21, 25], we found that 20, 60, 40, 17, and 6% patients were positive for fatigue, resistance, ambulation, illness, and loss-of-bodyweight domains, respectively, leading to 45.7% (n = 16) and 54.3% (n = 19) of the participants being categorized as none to mildly frail and moderately to severely frail, respectively (Table 2)

Read more

Summary

Introduction

Frailty is prevalent among patients with end-stage renal disease (ESRD) and is associated with an increased risk of cognitive impairment. Apart from its influence on cognition, it is currently unknown whether frailty affects subtler cerebral function in patients with ESRD. Patients with chronic kidney disease (CKD), end-stage renal disease (ESRD), exhibit a higher prevalence of frailty (i.e., 14–20% and 30–60%, respectively), which is at least 3–8-fold higher than that in the healthy, community-dwelling elderly population [1,2,3,4]. It is expected that an aging-related phenotype, including frailty, will be more prevalent in patients with renal insufficiency. Frailty may be an important, yet under-recognized opportunity, to avert the adverse consequences, which arise due to unsuccessful aging in patients with CKD [7]

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call